QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance 期刊论文 ANTI-CANCER DRUGS, 2016, 卷号: 27, 期号: 2 作者:  Gao, Ying;  Jiang, Mo;  Ma, Yuqin;  Wu, Shuang;  Li, Wenliang 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 drug-delivery system  nanoparticles  di-nuclear platinum prodrugs  endocytosis  ovarian cancer   Inorganic nanocarriers for platinum drug delivery 期刊论文 materials today, 2015, 卷号: 18, 期号: 10, 页码: 554-564 作者:  Ma,Ping'an;  Xiao,Haihua;  Li,Chunxia;  Dai,Yunlu;  Cheng,Ziyong 收藏  |  浏览/下载：40/0  |  提交时间：2016/04/29 NANOSCALE COORDINATION POLYMERS  GOLD NANOPARTICLES  ANTICANCER DRUGS  PRODRUG DELIVERY  PRO-DRUG  IN-VIVO  UPCONVERTING NANOPARTICLES  CELLULAR ACCUMULATION  SILICA NANOPARTICLES  ANTITUMOR-ACTIVITY   Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs 期刊论文 CHEMICAL COMMUNICATIONS, 2013, 卷号: 49, 期号: 42, 页码: 4809-4811 作者:  Xiao, Haihua;  Stefanick, Jared F.;  Jia, Xiaoyu;  Jing, Xiabin;  Kiziltepe, Tanyel 收藏  |  浏览/下载：12/0  |  提交时间：2019/04/09 Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs 期刊论文 chemical communications, 2013, 卷号: 49, 期号: 42, 页码: 4809-4811 Xiao HH; Stefanick JF; Jia XY; Jing XB; Kiziltepe T; Zhang Y; Bilgicer B 收藏  |  浏览/下载：17/0  |  提交时间：2014/04/18 ENHANCED ANTITUMOR EFFICACY  ANTICANCER DRUGS  CISPLATIN  COMPLEMENTARY  NANOMEDICINE  CONJUGATE  COMPLEXES  DESIGN  AGENTS  SHAPE   The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy 期刊论文 BIOMATERIALS, 2012, 卷号: 33, 期号: 33, 页码: 8657-8669 作者:  Xiao, Haihua;  Song, Haiqin;  Zhang, Yu;  Qi, Ruogu;  Wang, Rui 收藏  |  浏览/下载：18/0  |  提交时间：2019/04/09 Amphiphilic Copolymer  Drug Delivery Systems  Micelles  Multinuclear Platinum Drugs   The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy 期刊论文 BIOMATERIALS, 2012, 卷号: 33, 期号: 33 作者:  Xiao, Haihua;  Song, Haiqin;  Zhang, Yu;  Qi, Ruogu;  Wang, Rui 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 Amphiphilic copolymer  Drug delivery systems  Micelles  Multinuclear platinum drugs   The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy 期刊论文 biomaterials, 2012, 卷号: 33, 期号: 33, 页码: 8657-8669 Xiao HH; Song HQ; Zhang Y; Qi RG; Wang R; Xie ZG; Huang YB; Li YX; Wu Y; Jing XB 收藏  |  浏览/下载：19/0  |  提交时间：2013/04/22 CONFORMATIONAL-CHANGES  BIS(PLATINUM) COMPLEXES  BIODEGRADABLE POLYMER  ANTICANCER AGENTS  DNA-BINDING  PHASE-I  TRINUCLEAR  CARBOXYLATION  CISPLATIN(IV)  CYTOTOXICITY   A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity 期刊论文 JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2007, 卷号: 12, 期号: 5, 页码: 655-665 作者:  Fan, Damin;  Yang, Xiaoliang;  Wang, Xiaoyong;  Zhang, Shouchun;  Mao, Jiafei 收藏  |  浏览/下载：13/0  |  提交时间：2019/01/08 antitumor agent  dinuclear platinum complex  DNA  glutathione  guanosine-5 '-monophosphate